Lifecore Biomedical
LFCR
LFCR
92 hedge funds and large institutions have $235M invested in Lifecore Biomedical in 2021 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 26 increasing their positions, 34 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
17% less capital invested
Capital invested by funds: $285M → $235M (-$49.9M)
24% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 34
89% less call options, than puts
Call options by funds: $11K | Put options by funds: $98K
Holders
92
Holding in Top 10
3
Calls
$11K
Puts
$98K
Top Buyers
| 1 | +$15.2M | |
| 2 | +$5.13M | |
| 3 | +$3.9M | |
| 4 |
2L
22NW LP
Seattle,
Washington
|
+$2.79M |
| 5 |
ERSOT
Employees Retirement System of Texas
Austin,
Texas
|
+$787K |
Top Sellers
| 1 | -$4.36M | |
| 2 | -$2.05M | |
| 3 | -$1.98M | |
| 4 |
SCM
SG Capital Management
Chicago,
Illinois
|
-$1.63M |
| 5 |
Bank of New York Mellon
New York
|
-$1.18M |